United StatesMerck Emend (aprepitant) for oral suspension, 125 mg single‑dose kit (NDC 0006-3066-03; Lot Z014503, exp 11/15/2027) and Noxafil Powdermix (posaconazole) for delayed‑release oral suspension, 300 mg, 8 packets per carton (NDC 0085-2224-02; Lots Z012339, Z010344, Z009908, Z009909, exp 12/31/2026) are being recalled. The recall was issued because of the potential presence of metal particulate matter in the products. The products were distributed nationwide in the United States.
What's being recalled
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
Recalling firm: Merck Sharp & Dohme LLC, Wilson, NC, United States.
How to identify it
Lot #: Z014503, Exp 11/15/2027 Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026
The hazard
Presence of particulate matter: potential presence of metal particulates in the product.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the USA
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)